| 33.10 Data as of May 21 |  0.00 / 0.00%Today’s Change | 25.28 Today|||52-Week Range 36.25 | +19.93% Year-to-Date |
| Fresenius Teams with ApolloMed - Analyst Blog May 15 / Zacks.com |
| Previous close | 33.10 |
| Today’s open | n.a. |
| Day’s range | -- - -- |
| Volume | 0 |
| Average volume (3 months) | 464 |
| Market cap | $263.0M |
| Dividend yield | 1.49% |
| Earnings growth (last year) | +10.46% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +9.10% |
| Revenue growth (last year) | +8.42% |
| P/E ratio | -- |
| Price/Sales | 1.20 |
| Price/Book | 2.27 |
| Today’s change | Today’s % change | |
|---|---|---|
| DVADaVita HealthCare Pa... | -0.44 | -0.35% |
| FMSFresenius Medical Ca... | -0.36 | -1.04% |
| Next reporting date | July 30, 2013 |
| EPS forecast (this quarter) | $0.36 |
| Annual revenue (last year) | $13.9B |
| Annual profit (last year) | $1.2B |
| Net profit margin | 8.60% |
Sector Health Services |
Industry Medical/Nursing Services |
Chairman-Management Board & CEO Rice Powell |
CEO- Global Manufacturing Operations Kent Wanzek |
Corporate headquarters Bad Homburg vor der Höhe, Hessen |
.
